ArticleTranslational psychiatry2026
Lac-Phe elicits anxiolytic-like effects associated with monoaminergic signaling in mice.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety disorders are a growing public health concern in modern societies burdened with chronic stress and diminishing work motivation, imposing a substantial disease burden across all age groups. Lactoyl-phenylalanine (Lac-Phe), an endogenous metabolite produced during exercise and found in fermented foods, has recently gained attention for its metabolic regulatory functions, yet its potential anxiolytic effects remain unclear. In this study, we report that Lac-Phe administration elicits anxiolytic-like behavior in mice. Oral administration of Lac-Phe significantly increased open-arm exploration in the elevated plus maze (EPM), indicating anxiolytic-like activity. Similar behavioral effects were observed following intraperitoneal and intracerebroventricular administration in the EPM and the novelty-suppressed feeding test. Pharmacological blockade experiments indicated that dopamine D1 and serotonin 5-HT1A receptor signaling contribute to Lac-Phe-induced anxiolytic-like effects. Consistently, intraperitoneal administration of Lac-Phe increased dopamine tissue content in the hypothalamus and striatum and reduced hippocampal IL-1β and IL-6 mRNA expression. Together, these results suggest that Lac-Phe exerts anxiolytic-like effects, potentially involving monoaminergic signaling in the brain, and support further investigation of Lac-Phe as a food-derived metabolite in the context of stress- and anxiety-related outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.